Antimicrobial Peptide Cathelicidin-BF Inhibits Platelet Aggregation by Blocking Protease-Activated Receptor 4

A tryptophan derivative TD-26 attenuates thrombus formation by inhibiting both PI3K/Akt signaling and binding of fibrinogen to integrin αIIbβ3

(2015) Yahui Chen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Tripeptide SQL Inhibits Platelet Aggregation and Thrombus Formation by Affecting PI3K/Akt Signaling

(2015) Xing-li Su et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

The antimicrobial peptide cathelicidin-BF could be a potential therapeutic for Salmonella typhimurium infection

(2015) Xi Xia et al.   MICROBIOLOGICAL RESEARCH

Cathelicidin-BF, a Novel Antimicrobial Peptide from Bungarus fasciatus, Attenuates Disease in a Dextran Sulfate Sodium Model of Colitis

(2015) Haiwen Zhang et al.   MOLECULAR PHARMACEUTICS

A Novel Direct Factor Xa Inhibitory Peptide with Anti-Platelet Aggregation Activity from Agkistrodon acutus Venom Hydrolysates

(2015) Meimei Chen et al.   Scientific Reports

Targeting the anionic region of human protease-activated receptor 4 inhibits platelet aggregation and thrombosis without interfering with hemostasis

(2014) M. M. Mumaw et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

A novel peptide inhibitor of platelet aggregation from stiff silkworm, Bombyx batryticatus

(2013) Yi Kong et al.   PEPTIDES

Red blood cell distribution width and the risk of cardiovascular morbidity and all-cause mortality

(2013) Dahlia Weitzman et al.   THROMBOSIS AND HAEMOSTASIS

Inside-out, outside-in, and inside–outside-in: G protein signaling in integrin-mediated cell adhesion, spreading, and retraction

(2012) Bo Shen et al.   CURRENT OPINION IN CELL BIOLOGY

Severe thrombocytopenia and alveolar hemorrhage represent two types of bleeding tendency during tirofiban treatment: case report and literature review

(2012) Omer Celal Elcioglu et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Exploration of the Antiplatelet Activity Profile of Betulinic Acid on Human Platelets

(2012) Andreas G. Tzakos et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Pulmonary embolism and deep vein thrombosis

(2012) Samuel Z Goldhaber et al.   LANCET

Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110)

(2011) JY Suen et al.   BRITISH JOURNAL OF PHARMACOLOGY

Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes

(2011) Pierluigi Tricoci et al.   NEW ENGLAND JOURNAL OF MEDICINE

The antibacterial activity of BF-30 in vitro and in infected burned rats is through interference with cytoplasmic membrane integrity

(2011) Huimin Zhou et al.   PEPTIDES

Salvianolic acid A inhibits platelet activation and arterial thrombosis via inhibition of phosphoinositide 3-kinase

(2010) Z. S. HUANG et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Oxidative stress activates ADAM17/TACE and induces its target receptor shedding in platelets in a p38-dependent fashion

(2009) A. Brill et al.   CARDIOVASCULAR RESEARCH

Platelet receptors and signaling in the dynamics of thrombus formation

(2009) J. Rivera et al.   HAEMATOLOGICA

Protease-Activated Receptor 4 Uses Anionic Residues To Interact with α-Thrombin in the Absence or Presence of Protease-Activated Receptor 1†

(2008) Marvin T. Nieman   BIOCHEMISTRY

Src family tyrosine kinase Lyn mediates VWF/GPIb-IX-induced platelet activation via the cGMP signaling pathway

(2008) H. Yin et al.   BLOOD

Triggers, targets and treatments for thrombosis

(2008) Nigel Mackman   NATURE

Mechanisms of Thrombus Formation

(2008) Bruce Furie et al.   NEW ENGLAND JOURNAL OF MEDICINE